Enanta Pharmaceuticals
ENTA
#7360
Rank
S$0.57 B
Marketcap
S$19.89
Share price
5.92%
Change (1 day)
133.70%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Total assets

Total assets on the balance sheet as of September 2025 : S$0.36 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's total assets are S$0.36 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Enanta Pharmaceuticals - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-09-30S$0.48 B-23.35%
2023-09-30S$0.63 B17.19%
2022-09-30S$0.53 B-9.58%
2021-09-30S$0.59 B-10.17%
2020-09-30S$0.66 B-2.01%
2019-09-30S$0.67 B19.54%
2018-09-30S$0.56 B27.58%
2017-09-30S$0.44 B15.68%
2016-09-30S$0.38 B9.58%
2015-09-30S$0.35 B76.6%
2014-09-30S$0.19 B35.06%
2013-09-30S$0.14 B129.03%
2012-09-30S$64.1 M89.13%
2011-09-30S$33.89 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AbbVie
ABBV
S$173.06 B 47,596.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$249.21 B 68,583.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$32.13 B 8,756.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$167.43 B 46,045.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.22 B 34,412.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$138.67 B 38,117.59%๐Ÿ‡จ๐Ÿ‡ญ Switzerland